Ocular melanoma
MONDO:0006325A melanoma that arises from the structures of the eye or ocular adnexa.
Also known as: eye melanoma, eye melanoma (disease), eyeball of camera-type eye melanoma, eyeball of camera-type eye melanoma (disease), melanoma (disease) of eyeball of camera-type eye, melanoma of eye, melanoma of the eye, ocular melanoma
2924 clinical trials for this condition and its sub-types, 15 tagged with Ocular melanoma itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Sub-types of Ocular melanoma
-
Uveal melanoma 98 trials · 102 incl. sub-types
8 sub-types
- Malignant choroid melanoma 10 trials Sub-types →
- Iris melanoma 4 trials Sub-types →
- Posterior uveal melanoma 0 trials · 3 incl. sub-types Sub-types →
- Epithelioid cell uveal melanoma 0 trials Sub-types →
- Intermediate cell type uveal melanoma 0 trials Sub-types →
- Mixed cell uveal melanoma 0 trials Sub-types →
- Necrotic uveal melanoma 0 trials Sub-types →
- Spindle cell intraocular melanoma 0 trials Sub-types →
-
Malignant conjunctival melanoma 4 trials
-
Eyelid melanoma 0 trials
-
Malignant cornea melanoma 0 trials
-
Retinal melanoma 0 trials
Most studied deeper sub-types
-
New combo therapy aims to supercharge immune cells against tough melanoma
Disease control Recruiting nowThis early-phase study tests a new drug (IOV-3001) designed to boost immune cells in people with advanced melanoma that has not responded to prior treatments. About 42 adults will receive the drug alongside a personalized cell therapy called lifileucel. The main goals are to chec…
Phase 1/2 • Sponsor: Iovance Biotherapeutics, Inc. • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
How does eye cancer treatment affect daily life? new study aims to find out
Knowledge-focused Recruiting nowThis study tracks how choroidal melanoma and its treatment affect patients' quality of life. It involves 15 people already in a larger Phase 3 trial. Participants fill out questionnaires about their well-being over two years. No new drugs or procedures are tested here.
Sponsor: Aura Biosciences • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:06 UTC